Shree Ganesh Bio-Tech (India) Limited (BOM:539470)
India · Delayed Price · Currency is INR 0.6100
+0.0100 (1.67%)
At close: Jun 2, 2026
BOM:539470 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 49.71 | 229.58 | 202.78 | 624.55 | 726.44 |
Other Revenue | - | - | - | - | 0 |
| 49.71 | 229.58 | 202.78 | 624.55 | 726.44 | |
Revenue Growth (YoY) | -78.35% | 13.22% | -67.53% | -14.03% | 322.01% |
Cost of Revenue | 50.56 | 226.41 | 200.31 | 596.29 | 688.37 |
Gross Profit | -0.85 | 3.17 | 2.46 | 28.25 | 38.08 |
Selling, General & Admin | 1.65 | 1.03 | 1.95 | 2.23 | 2.47 |
Other Operating Expenses | 7.08 | 12.67 | 2.52 | 4.52 | 1.11 |
Operating Expenses | 8.73 | 13.71 | 4.47 | 6.76 | 3.59 |
Operating Income | -9.58 | -10.54 | -2.01 | 21.49 | 34.49 |
Interest & Investment Income | - | 14.41 | 10.56 | 3.31 | 0 |
Other Non Operating Income (Expenses) | 14.72 | -0 | -0 | - | -0 |
EBT Excluding Unusual Items | 5.14 | 3.87 | 8.55 | 24.8 | 34.49 |
Gain (Loss) on Sale of Assets | - | - | - | 2.34 | 0.5 |
Pretax Income | 5.14 | 3.87 | 8.55 | 27.14 | 35 |
Income Tax Expense | 1.37 | 1.09 | 2.34 | 6.76 | 9.74 |
Net Income | 3.78 | 2.78 | 6.21 | 20.39 | 25.26 |
Net Income to Common | 3.78 | 2.78 | 6.21 | 20.39 | 25.26 |
Net Income Growth | 35.63% | -55.15% | -69.55% | -19.29% | 697.39% |
Shares Outstanding (Basic) | 378 | 399 | 399 | 399 | 399 |
Shares Outstanding (Diluted) | 378 | 399 | 399 | 399 | 399 |
Shares Change (YoY) | -5.27% | - | - | - | - |
EPS (Basic) | 0.01 | 0.01 | 0.02 | 0.05 | 0.06 |
EPS (Diluted) | 0.01 | 0.01 | 0.02 | 0.05 | 0.06 |
EPS Growth | 43.18% | -55.15% | -68.86% | -21.09% | 697.45% |
Free Cash Flow | -81.96 | -102.12 | 101.58 | 105.4 | 35.67 |
Free Cash Flow Per Share | -0.22 | -0.26 | 0.26 | 0.26 | 0.09 |
Gross Margin | -1.71% | 1.38% | 1.21% | 4.52% | 5.24% |
Operating Margin | -19.27% | -4.59% | -0.99% | 3.44% | 4.75% |
Profit Margin | 7.60% | 1.21% | 3.06% | 3.26% | 3.48% |
Free Cash Flow Margin | -164.88% | -44.48% | 50.09% | 16.88% | 4.91% |
EBITDA | -9.58 | -10.54 | -2 | 21.5 | 34.5 |
EBITDA Margin | -19.26% | -4.59% | -0.99% | 3.44% | 4.75% |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
EBIT | -9.58 | -10.54 | -2.01 | 21.49 | 34.49 |
EBIT Margin | -19.27% | -4.59% | -0.99% | 3.44% | 4.75% |
Effective Tax Rate | 26.55% | 28.04% | 27.40% | 24.89% | 27.82% |
Revenue as Reported | 64.43 | 243.99 | 213.34 | 630.19 | 726.95 |
Advertising Expenses | - | 0.02 | 0.07 | 0.02 | - |